Opioids

In his PUPC 2024 session, "Using the Most Recent Safe Opioid Prescribing and Alternative Therapy Guidelines in Primary Care" Dr Hudspeth provided an overview of the national guidelines for managing pain...

Although more patients are seeking pain relief in primary care settings, practitioners may not have the experience in managing and treating patients with complex pain situations or may not be familiar with...

Researchers examined how the use of spinal anesthesia in those undergoing lumbar spine surgery reduced the use of polypharmacy and opioids, and ultimately the risk of adverse events, in older adults.

A team of researchers examined the possibility of harmful risks associated with the discontinuation of long-term benzodiazepine use in patients.

Nearly 108,000 Americans died of drug overdoses in 2022, surpassing the previous year’s record total, according to a CDC report. Although the official number of deaths caused by overdoses—107,941—breaks the...

Researchers analyzed trends in opioid prescribing for patients who have undergone dental procedures.

Researchers evaluated the use of opioid use disorder (OUD) medication prior to surgery in patients with OUD to determine whether the risk of overdose or complications are reduced. The findings of the study...

The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.

The FDA has approved a new buprenorphine treatment option for people with opioid use disorder following clinical trials that tested its safety and efficacy.

This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...